SKPO Stock UPDATES Skye Petroleum Inc (SKPO) 0.0800 09/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Skye Petroleum Inc (SKPO) 0.0800 $SKPO

Skye Petroleum Acquires Patented Technology for the Removal of Volatile Phosphate from Hydrocarbon Based Fracturing Fluids
PR Newswire - Mon Feb 24, 6:00AM CST
Skye Petroleum, Inc. (Pink Sheets: SKPO) is pleased to announce that it has acquired (from a private company) a patent recently issued by the U.S. Patent and Trademark Office. The patented technology provides a method to selectively remove volatile phosphates from hydrocarbon based fracturing fluids used to stimulate certain crude oil and gas wells. The source of volatile phosphates found in fracturing fluids originates from certain additives that are part of the fracturing fluids' formulation. Additionally, the use of the technology has shown secondary benefits including clarifying and removing certain contaminant metals from hydrocarbon fluids.

Skye Petroleum, Inc. Opens New Office in Bossier City, LA
PR Newswire - Thu Jan 16, 6:00AM CST
Skye Petroleum, Inc. (Pink Sheets: SKPO) is pleased to announce the opening of a new office in Bossier City, Louisiana. Billy Joe Edwards, who brings almost 30 years of experience in the oil and gas industry, will be joining Skye Petroleum as its Executive Vice President of Development. Edwards will lead this new office, which gives Skye Petroleum a closer location to better serve the markets in north Louisiana, Arkansas, Mississippi, East Texas and Oklahoma. Edwards, as the inventor of the Endurance Brand Rod Guide in the mid 1980s, has built a solid reputation among his many contacts in the oil industry throughout the United States and other parts of the world (Australia, Indonesia, Vietnam, Canada, Romania, etc.). Edwards will focus on product testing, technical assistance for end users, sales and development of the overall Skye brand. Edwards said, "It is an exciting time to be a part of Skye Petroleum. The company has a diverse product line that can solve some of the industry's biggest problems that have plagued oil and gas fields for decades. I have been working with Skye's products for a couple of years now and have seen firsthand, some amazing results. Increasing production is what oil producers desire most and Skye's technology has worked better than anything I have ever seen."

Skye Petroleum, Inc. Chemical Sales More than Triple in 2013
PR Newswire - Mon Dec 30, 6:00AM CST
Skye Petroleum, Inc. (Pink Sheets: SKPO) is pleased to announce that chemical sales have more than tripled in 2013 versus 2012. Skye anticipates continued strong sales growth in 2014 as the paraffin and aphaltene dispersant technologies are introduced into more regions of the United States and in certain parts of the world. Skye will complete 2013 with its strongest cash position in recent years, with no short or long term debt, and with all current liabilities paid.

Skye Petroleum, Inc. Chemical Sales Hit Consecutive Record Breaking Quarters
PR Newswire - Mon Aug 19, 6:30AM CDT
Skye Petroleum, Inc. (Pink Sheets: SKPO) is pleased to announce that in the first six (6) weeks of the third quarter of 2013, sales have already surpassed the record sales in the most recent second quarter. Also, sales of its Skye Chem Wax-Dispersant Ready to Use chemical (WD-RTU) in 2013, have now doubled the chemical sales of 2012. Skye attributes the sales growth to focusing on selling through a network of distributors. The company has sold through multiple distributors in Pennsylvania, Alabama, Louisiana and Texas over the past year. Skye has also added Account Executives in Houston to expand its marketing efforts across the United States.

Skye Petroleum, Inc. Adds Distribution Partner in NW Pennsylvania
PR Newswire - Mon Apr 29, 3:13PM CDT
Skye Petroleum, Inc. (Pink Sheets: SKPO), ("Skye" or the "company" is pleased to announce that Hoover Oil Field Supply in Clarendon, PA is offering the company's primary chemical technology, Skye Chem Wax Dispersant-Ready to Use (WD-RTU), to its customers in the northwest and central Pennsylvania region. Hoover is a well-known supplier in the region and has been pleased with the responses they are receiving from customers who purchased Skye's technology.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 114

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 7

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 172

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 215

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today

Updated Category News Views 66

A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 207

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 122

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 26

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading

Top 5 Most Recently Viewed Articles

T-Mobile US: A Decade of Impressive Stock Growth Revealed

Updated Category News Views 142

T-Mobile US and Its Remarkable Growth Journey T-Mobile US (NASDAQ: TMUS) has shown exceptional growth over the last decade. With an annualized return rate of 20.05%, the company has outpaced the broader market by 8.22%. As of the latest information available, T-Mobile's market capitalization stands at an impressive $269.40 billion, highlighting its substantial position...

Continue Reading
Analysts Adjust TFI International's Forecasts After Q3 Report

Updated Category News Views 67

TFI International Reports Weaker-Than-Expected Q3 Earnings After the market closed on a recent Monday, TFI International (NYSE: TFII) announced its quarterly earnings figures, which unfortunately fell below expectations. The company reported earnings of $1.60 per share, compared to analyst predictions of $1.78 per share. In addition, TFI International's quarterly revenue...

Continue Reading
C3.ai Investors Face Class Action Amidst Poor Financial Results

Updated Category News Views 179

C3.ai Class Action Overview The Portnoy Law Firm is stepping forward to represent investors of C3.ai, Inc. as a class action develops. This legal move comes after concerning preliminary financial results announced by the company. Investors who purchased securities of C3 during the specified class period are encouraged to engage with the firm. Details of the Legal Class...

Continue Reading
21st.BIO Seeks EU Nod for Precision Fermentation Tech

Updated Category News Views 172

Is Precision Fermentation Europe's Next Big Bet? Here we go again with another tech trying to revolutionize the food industry, and this time it's the Danish company 21st.BIO making strides in Europe. They've tossed their hat in the ring with an EU Novel Food application for BLG Essential+™, hoping to weave precision fermentation into the fabric of European food...

Continue Reading
Key Pfizer Executives Support Current Leadership Amid Challenges

Updated Category News Views 105

Support for Pfizer's Leadership from Former Executives In a recent statement, former Pfizer executives, Ian Read and Frank D'Amelio, clarified their stance regarding the ongoing campaign by activist investor Starboard Value. They emphasized that they will not be engaging with Starboard, which has been advocating for changes within the pharmaceutical giant to enhance its...

Continue Reading